• GPGI, Inc. reported first‑quarter 2026 results on May 7, 2026, swinging from US$21.5 million net income a year earlier to a US$235 million net loss as the first set of accounts to fully reflect the US$5 billion Husky Technologies acquisition.
• The loss was driven largely by a US$154.1 million hit tied to its equity method investment in GPGI Holdings, even as CompoSecure delivered record sales under the Resolute Operating System and the board appointed Ian Snadden to accelerate international growth.
• We’ll now examine how GPGI’s first post‑Husky quarter, combining record CompoSecure sales with Husky headwinds, reshapes its investment narrative.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

GPGI Investment Narrative Recap

To own GPGI, you have to believe the CompoSecure and Husky combination can turn higher consolidated sales into durable earnings, despite near term volatility. The first post Husky quarter reinforces that the key short term catalyst is execution on integration and margin recovery, while the biggest current risk is that Husky’s market headwinds and the large equity method loss keep masking underlying operating progress. This quarter materially raises the bar for how quickly management needs to show cleaner profitability.

Among recent announcements, the most relevant here is the disclosure that GPGI’s US$3.1 billion equity method investment in GPGI Holdings produced US$407.8 million of net sales and US$88.8 million of Adjusted EBITDA in Q1 2026. That context matters for assessing whether the US$235 million net loss is primarily accounting driven or signals deeper earnings pressure, and how much cushion the core CompoSecure and Husky operations provide against further integration and macro bumps.

Yet behind CompoSecure’s record card sales, investors should be aware that accelerating digital payment adoption could still...

GPGI's narrative projects $1.9 billion revenue and $410.9 million earnings by 2029. This requires 216.1% yearly revenue growth and a $546.9 million earnings increase from -$136.0 million today.

Uncover how GPGI's forecasts yield a $24.33 fair value, a 88% upside to its current price.

Exploring Other Perspectives

Before this quarter, the most cautious analysts already assumed very ambitious improvement, with revenue reaching about US$1.1 billion and earnings near US$321 million by 2029, so you should expect that both their more optimistic growth catalysts and their concerns about long term digital payment risks may evolve as the impact of Husky’s weak quarter becomes clearer.

Explore 4 other fair value estimates on GPGI - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your GPGI research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free GPGI research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate GPGI's overall financial health at a glance.

Seeking Other Investments?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Find 51 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.